Market Overview

UPDATE: Stifel Nicolaus Initiates Stryker Corporation at Buy on Valuation

Share:
Related SYK
Goldman Remains Constructive on MedTech, Sees 'New Opportunities' Amid Selloff
2 Medical Technology Stocks To Weather Market Pullback

Stifel Nicolaus initiated coverage on Stryker Corporation (NYSE: SYK) with a Buy rating and a $65 price target.

Stifel Nicolaus noted, "The recent appointment of CEO, Kevin Lobo, formerly head of Stryker's Reconstructive Products Division, ends an extended period of leadership uncertainty. … On an absolute basis, SYK trades at 12.2x and 6.5x our 2013 EPS and EBITDA (EV/EBITDA) estimates, respectively. These current multiples represent discounts to the average SYK P/E and EV/EBITDA multiples, since 2009, of 13.8x and 8.0x, respectively."

Stryker Corporation closed at $52.10 on Monday.

Latest Ratings for SYK

DateFirmActionFromTo
Aug 2015Stifel NicolausMaintainsBuy
Aug 2015Credit SuisseAssumesOutperform
Jul 2015Canaccord GenuityMaintainsBuy

View More Analyst Ratings for SYK
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (SYK)

Get Benzinga's Newsletters